Study of Talactoferrin Oral Solution for Nosocomial Infection in Preterm Infants
Status:
Unknown status
Trial end date:
2012-12-01
Target enrollment:
Participant gender:
Summary
This study will evaluate the safety, toxicity and efficacy of talactoferrin in reducing the
incidence of all nosocomial infections in prematurely-born infants.